AstraZeneca PLC AZN
AZN Rating
AZN Rating Factors
AZN Company Overview
AstraZeneca PLC is a global biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of prescription medicines. The company operates primarily in the industries of oncology, rare diseases, cardiovascular, renal and metabolism, respiratory and immunology, vaccines, and infectious diseases. AstraZeneca generates revenue through sales of branded pharmaceutical products, strategic collaborations, licensing agreements, and research partnerships. Its largest revenue drivers have included oncology therapies such as Tagrisso, Imfinzi, Lynparza, and Enhertu, alongside medicines in cardiovascular and rare disease categories.
The company serves healthcare providers, hospitals, governments, and patients across both developed and emerging markets. AstraZeneca is recognized for its strong oncology pipeline, extensive biologics capabilities, and integration of advanced scientific platforms including antibody-drug conjugates, cell therapies, and precision medicine technologies. AstraZeneca was formed in 1999 through the merger of Sweden-based Astra AB and the UK-based Zeneca Group. The company expanded significantly through acquisitions including MedImmune, Alexion Pharmaceuticals, and partnerships with biotechnology firms and academic institutions, helping evolve it into one of the world’s largest research-driven pharmaceutical companies.
AZN Income Statement
AZN Balance Sheet
AZN Price History
AZN Valuation
AZN Dividends and Shares
AZN Corporate Info
Cambridge Biomedical Campus
Cambridge, CB2 0AA